Brawn Laboratories Limited Roxithromycin Export Data — India (DGFT 2022–2026)

Name: Brawn Laboratories Limited Roxithromycin Export Records India — #1 Exporter, 14 Shipments, $700.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Roxithromycin

India Pharmaceutical Trade Intelligence

$4.2M78 Suppliers30 CountriesHS 30049099

ExportsIndia → VIETNAM33.9%India → CAMBODIA18.3%

ImportsGERMANY → India$752

#1 Supplier: BRAWN LABORATORIES

Brawn Laboratories Limited — Roxithromycin Exporter #1 | $700.0K Trade Value | TransData Nexus | TransData Nexus

Brawn Laboratories Limited — Roxithromycin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Roxithromycin · $700.0K export value · DGFT Verified

Brawn Laboratories Limited is the #1 Indian exporter of Roxithromycin with $700.0K in export value and 14 verified shipments. Brawn Laboratories Limited holds a 16.8% market share in Roxithromycin exports across 4 countries. The company exports 17 pharmaceutical products worth $22.6M across 10 therapeutic categories.

Brawn Laboratories Limited — Roxithromycin Export Profile: Buyers & Destinations

Brawn Laboratories Limited Roxithromycin export treemap — buyers and destination countries | TransData Nexus

Where Does Brawn Laboratories Limited Export Roxithromycin?

Country	Value	Shipments	Share
VIETNAM	$178.5K	5	52.1%
VIETNAM, DEMOCRATIC REP. OF	$100.0K	2	29.2%
CAMBODIA	$31.5K	4	9.2%
THAILAND	$29.8K	2	8.7%

Who Are the Top Buyers of Roxithromycin from Brawn Laboratories Limited?

Buyer	Country	Value	Orders
MILITARY COMMERICAL JOINT STOCK BANK	VIETNAM	$128.5K	4
ASIA COMMERCIAL BANK	VIETNAM, DEMOCRATIC REP. OF	$50.0K	1
MILITARY COMMERCIAL JOINT STOCK	VIETNAM	$50.0K	1
MILITARY COMMERICAL JOINT STOCK.	VIETNAM, DEMOCRATIC REP. OF	$50.0K	1
GRACE WIN COMPANY LIMITED	MYANMAR	$32.8K	3
ADVANCED BANK OF ASIA	CAMBODIA	$31.5K	4

Brawn Laboratories Limited supplies Roxithromycin to 6 buyers globally. The largest buyer is MILITARY COMMERICAL JOINT STOCK BANK (VIETNAM), followed by ASIA COMMERCIAL BANK (VIETNAM, DEMOCRATIC REP. OF) and MILITARY COMMERCIAL JOINT STOCK (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Roxithromycin Formulations Does Brawn Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
ROXITHROMYCIN TABLETS 150MG (WHITE CIRCU	$115.2K	3
ROXITHROMYCIN TABLETS 150MG WHITE CIRCULAR BICONVEX FILM COATED TABLETS- B/NO.BNT0523022BNT0523023BNT0523024*	$100.0K	2
ROXITHROMYCIN TABLETS 150MG WHITE CIRCULAR BICONVEX FILM COATED TABLETS B NO BNT0323003 BNT0323004 BNT0323005	$50.0K	1
ROXITHROMYCIN TABLETS 150MG WHITE CIRCULAR BICONVEX FILM COATED TABLETS	$29.8K	2
ROXITHROMYCIN TABLETS 150MG WHITE CIRCULAR BICONVEXFILM COATED TABLETS-B/NO.BNT0523022 D/M:11/05/2023 D/E:10/05/2026	$28.5K	2
ROXITHROMYCIN TABLETS 150 MG (WHITE CIRCULAR BICONVEX FILM COATED TABLETS)NOS	$16.4K	3
ROXITHROMYCIN TABLETS 150MG WHITE CIRCULAR BICONVEX FILM COATED TABLETS B NO BNT0123062	$3.0K	1

Brawn Laboratories Limited exports 7 distinct Roxithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ROXITHROMYCIN TABLETS 150MG (WHITE CIRCU with 3 shipments worth $115.2K.

How Does Brawn Laboratories Limited Compare to Nearest Roxithromycin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	STRIDES PHARMA SCIENCE LIMITED	$758.8K	54	1	$14.1K
1	BRAWN LABORATORIES LIMITED ★	$700.0K	14	4	$50.0K
3	MARKSANS PHARMA LIMITED	$598.0K	15	2	$39.9K
4	TORRENT PHARMACEUTICALS LTD	$191.6K	14	2	$13.7K

Brawn Laboratories Limited ranks #1 among 78 Indian Roxithromycin exporters. Average shipment value of $50.0K compared to the market average of $36.7K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and MARKSANS PHARMA LIMITED.

Which Indian Ports Ship Roxithromycin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	64	15.0%
SAHAR AIR CARGO ACC (INBOM4)	40	9.4%
SAHAR AIR	35	8.2%
Bombay Air	29	6.8%
NHAVA SHEVA SEA (INNSA1)	25	5.9%
DELHI AIR	24	5.6%
TUGLAKABAD ICD	14	3.3%
BANGALORE ICD	14	3.3%

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Roxithromycin Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Brawn Laboratories. The Israel-Iran tensions have escalated security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, leading to major carriers suspending or restricting transits. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, as reported by industry executives and insurers. (livemint.com)

In the United States, policy shifts towards reshoring pharmaceutical manufacturing and imposing tariffs on imports have prompted Indian companies to invest in U.S. facilities. This strategy aims to mitigate tariff impacts and secure market access. For instance, Indian firms have invested between $500-700 million in U.S. hubs during the partial fiscal year 2025-26, focusing on oncology and biologics. (odrindia.in) Such investments are crucial for maintaining competitiveness in the U.S. market amidst evolving trade policies.

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive. Indian exporters must navigate these regulations to ensure market access, emphasizing the need for robust quality assurance and compliance frameworks. Brawn Laboratories' adherence to these standards is vital for sustaining and expanding its European market presence.

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international quality standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified inspections and enforcement actions, necessitating stringent adherence to Good Manufacturing Practices (GMP). Instances of non-compliance have led to import bans and reputational damage for some Indian firms. (comcec.org) Therefore, Brawn Laboratories must prioritize quality control and regulatory compliance to maintain its export licenses and market credibility.

The Indian government's initiatives to bolster the pharmaceutical sector's compliance infrastructure, including the establishment of a dedicated 'CBAM Facilitation Cell' to assist exporters with complex reporting requirements, reflect a commitment to enhancing global competitiveness. (sgeexport.com) Brawn Laboratories' proactive engagement with these initiatives can further strengthen its compliance posture.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Roxithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Brawn Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 14 individual customs records matching Brawn Laboratories Limited exporting Roxithromycin, covering 7 formulations to 5 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 30+ countries, 125+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Roxithromycin

Roxithromycin

Brawn Laboratories Limited — Roxithromycin Exporter Profile

Brawn Laboratories Limited — Roxithromycin Export Profile: Buyers & Destinations

Where Does Brawn Laboratories Limited Export Roxithromycin?

Who Are the Top Buyers of Roxithromycin from Brawn Laboratories Limited?

What Is India's Total Roxithromycin Export Value and How Much Does Brawn Laboratories Limited Contribute?

What Is the Average Shipment Value for Brawn Laboratories Limited's Roxithromycin Exports?

How Does Brawn Laboratories Limited Compare to Other Indian Roxithromycin Exporters?

What Roxithromycin Formulations Does Brawn Laboratories Limited Export?

How Does Brawn Laboratories Limited Compare to Nearest Roxithromycin Exporters?

Which Indian Ports Ship Roxithromycin Exports?

What Other Advanced Antibiotics Products Does Brawn Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Roxithromycin Exports

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

About Brawn Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Roxithromycin Export Data from Brawn Laboratories Limited

Roxithromycin Stats

Company Overview

Top Products by Brawn Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source